Which medications in the drug class Mineralocorticoids are used in the treatment of Cerebral Salt-Wasting Syndrome?

Updated: May 13, 2020
  • Author: Sudha Garimella, MBBS; Chief Editor: Sasigarn A Bowden, MD  more...
  • Print


Mineralocorticoids enhance sodium reabsorption in the kidney by direct action on distal tubule cells, resulting in expanded extracellular fluid volume. They increase renal excretion of potassium and hydrogen ion.


Fludrocortisone promotes the increased reabsorption of sodium and the loss of potassium by the renal distal tubules.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!